Reocclusion three months after successful thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activating complex

This publication has 19 references indexed in Scilit:

• Effect of reperfusion on electrocardiographic and enzymatic infarct size: Results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction
  American Heart Journal, 1988
• Thrombolytic Therapy: Current Status
  New England Journal of Medicine, 1988
• Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Anisoylated Plasminogen Streptokinase Activator Complex (APSAC)
  Drugs, 1987
• Does the quantitative assessment of coronary artery dimensions predict the physiologic significance of a coronary stenosis?
  Circulation, 1987
• A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)
  New England Journal of Medicine, 1986
• Rapid Lysis of Coronary Artery Thrombi with Anisoylated Plasminogen: Streptokinase Activator Complex
  Annals of Internal Medicine, 1986
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.
  Circulation, 1985
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980